Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lipinski

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Thrombosis Research|August 1, 1976
Evaluation of antithrombotic properties of suloctidil in comparison with aspirin and dipyridamoleV Gurewich, B Lipinski
The American Journal of the Medical Sciences|July 1, 1977
Case report: low-dose intravenous heparin in the treatment of disseminated intravascular coagulationV Gurewich, B Lipinski
Lancet (London, England)|February 10, 1979
Alpha 2-plasmin inhibitor deficiencyB Lipinski, V Gurewich
Annals of Internal Medicine|October 1, 1974
Letter: Heparin dosage and clotting timeV Gurewich, B Lipinski
Thrombosis Research|March 1, 1976
The effect of leukopenia versus thrombocytopenia on endotoxin induced intravascular coagulationB Lipinski, V Gurewich
American Journal of Clinical Pathology|March 1, 1976
Semiquantitative determination of soluble fibrin monomer complexes by chromatography and serial-dilution protamine sulfate testV Gurewich, B Lipinski
Thrombosis Research|January 1, 1976
Letter: The degradation of soluble versus insoluble fibrin in vivoB Lipinski, V Gurewich
Magnesium Research|January 12, 2001
Effect of magnesium on fibrin formation from lower molecular weight (LMW) fibrinogenB Lipinski, I Lipinska
Thrombosis Et Diathesis Haemorrhagica|November 15, 1975
Proceedings: The role of platelets and leukocytes in endotoxin-induced disseminated intravascular coagulation (DIC)V Gurewich, B Lipinski
Heart, Lung & Circulation|December 11, 2012
Differences in morphology of fibrin clots induced with thrombin and ferric ions and its pathophysiological consequencesE Pretorius, B Lipinski
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Thrombosis Research|August 1, 1976
Evaluation of antithrombotic properties of suloctidil in comparison with aspirin and dipyridamoleV Gurewich, B Lipinski
The American Journal of the Medical Sciences|July 1, 1977
Case report: low-dose intravenous heparin in the treatment of disseminated intravascular coagulationV Gurewich, B Lipinski
Lancet (London, England)|February 10, 1979
Alpha 2-plasmin inhibitor deficiencyB Lipinski, V Gurewich
Annals of Internal Medicine|October 1, 1974
Letter: Heparin dosage and clotting timeV Gurewich, B Lipinski
Thrombosis Research|March 1, 1976
The effect of leukopenia versus thrombocytopenia on endotoxin induced intravascular coagulationB Lipinski, V Gurewich
American Journal of Clinical Pathology|March 1, 1976
Semiquantitative determination of soluble fibrin monomer complexes by chromatography and serial-dilution protamine sulfate testV Gurewich, B Lipinski
Thrombosis Research|January 1, 1976
Letter: The degradation of soluble versus insoluble fibrin in vivoB Lipinski, V Gurewich
Magnesium Research|January 12, 2001
Effect of magnesium on fibrin formation from lower molecular weight (LMW) fibrinogenB Lipinski, I Lipinska
Thrombosis Et Diathesis Haemorrhagica|November 15, 1975
Proceedings: The role of platelets and leukocytes in endotoxin-induced disseminated intravascular coagulation (DIC)V Gurewich, B Lipinski
Heart, Lung & Circulation|December 11, 2012
Differences in morphology of fibrin clots induced with thrombin and ferric ions and its pathophysiological consequencesE Pretorius, B Lipinski
Pageof 6